Prochlorperazine
General Information
Prochlorperazine Impurities and Prochlorperazine
Daicel Pharma offers the best quality Prochlorperazine impurities, N-Nitroso Desmethyl Prochlorperazine. They are vital for evaluating the quality, stability, and biological safety of Prochlorperazine. Furthermore, Daicel Pharma specializes in the custom synthesis of Prochlorperazine impurities and ensures their worldwide delivery.
Prochlorperazine [CAS: 58-38-8] a phenothiazine derivative, helps in schizophrenia treatment and other psychotic symptoms. As an antipsychotic drug, Prochlorperazine treats conditions of mental illness. In addition, Prochlorperazine helps in treating patients suffering from nausea and vomiting after chemotherapy and radiation therapy.
Prochlorperazine: Use and Commercial Availability
Prochlorperazine treats schizophrenia and its symptoms of hallucinations, agitation, delusions, etc. It also treats nausea and vomiting in patients before and after surgery. Further, it is helpful in the treatment of migraine. Prochlorperazine can be administered by routes-oral, intramuscular parenteral, and rectal. Thus, drug dosing and formulation also vary according to the medical conditions. Many generic manufacturers supply Prochlorperazine under different brand names. Some of them are Compro, Compazine, Procomp, etc.
Prochlorperazine Structure and Mechanism of Action
The chemical name of Prochlorperazine is 2-Chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine. The chemical formula for Prochlorperazine is C20H24ClN3S, and its molecular weight is approximately 373.94 g/mol.
Prochlorperazine inhibits D2 dopamine receptors, thus reducing psychotic symptoms.
Prochlorperazine Impurities and Synthesis
During the synthesis of Prochlorperazine , impurities may form that may affect the safety and efficacy of the drug. These impurities form during the synthesis, storage, or degradation of Prochlorperazine. So, Prochlorperazine impurities must be controlled and monitored throughout the drug’s lifecycle.
Daicel Pharma offers a comprehensive Certificate of Analysis (CoA) for Prochlorperazine impurities, which includes N-Nitroso Desmethyl Prochlorperazine. The issued CoA is from a cGMP-compliant analytical facility. It contains characterization data such as 1H NMR, 13C NMR, IR, MASS, and HPLC purity. We give additional spectral data on request.Daicel Pharma can prepare any unidentified Prochlorperazine impurity or degradation product. In addition, Daicel Pharma offers highly purified Stable isotope-labeled standards of Prochlorperazine for bioanalytical research and BA/BE studies. We also provide a complete characterization report on delivery.
References
FAQ's
References
- Horclois, Raymond J., Phenthiazine derivatives and processes for the preparation, GB780193A, July 31, 1957, Societe des usines chimiques de Rhone-Poulenc (https://www.lens.org/lens/patent/173-638-741-347-623/frontpage?l=en)
- Sankey, M. G.; Holt, Jacquelyn E.; Kaye, C. M., A simple and sensitive HPLC method for the assay of prochlorperazine in plasma, British Journal of Clinical Pharmacology, Volume: 13, Issue: 4, Pages: 578-80, 1982 DOI: (10.1111/j.1365-2125.1982.tb01427.x)
- Fowler, A.; Taylor, W.; Bateman, D. N., Plasma prochlorperazine assay by high-performance liquid chromatography-electrochemistry, Journal of Chromatography, Biomedical Applications, Volume: 380, Issue: 1, Pages: 202-5, 1986 DOI: (1016/s0378-4347(00)83644-0)
Frequently Asked Questions
What are the known Prochlorperazine impurities?
Dimer impurities, sulfoxide impurity, 2-chloro-phenothiazine, and perazine impurity are some of the known impurities of Prochlorperazine.
How do Prochlorperazine degradation products form?
Reactions like hydrolysis, N-alkylation, cleavage of C-C bond, and C-N bond cleavage may cause the formation of Prochlorperazine degradation products.
Why is it necessary to set the acceptable limits for Prochlorperazine Impurities?
By setting the acceptable limits for Prochlorperazine Impurities, regulatory authorities ensure the final drug is safe and high-quality.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.